Title |
Type 2 diabetes mellitus in the pathophysiology of Alzheimer's disease
|
---|---|
Published in |
Dementia & Neuropsychologia, January 2017
|
DOI | 10.1590/1980-57642016dn11-020002 |
Pubmed ID | |
Authors |
Aparecida Marcelino de Nazareth |
Abstract |
Both Alzheimer's disease (AD) and type 2 diabetes mellitus (DM) are two common forms of disease worldwide and many studies indicate that people with diabetes, especially DM, are at higher risk of developing AD. AD is characterized by progressive cognitive decline and accumulation of β-amyloid (Aβ) forming senile plaques. DM is a metabolic disorder characterized by hyperglycemia in the context of insulin resistance and relative lack of insulin. Both diseases also share common characteristics such as loss of cognitive function and inflammation. Inflammation resulting from Aβ further induces production of Aβ1-42 peptides. Inflammation due to overnutrition induces insulin resistance and consequently DM. Memory deficit and a decrease in GLUT4 and hippocampal insulin signaling have been observed in animal models of insulin resistance. The objective of this review was to show the shared characteristics of AD and DM. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 98 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 20 | 20% |
Student > Ph. D. Student | 11 | 11% |
Researcher | 10 | 10% |
Student > Master | 8 | 8% |
Other | 7 | 7% |
Other | 15 | 15% |
Unknown | 27 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 17% |
Biochemistry, Genetics and Molecular Biology | 14 | 14% |
Neuroscience | 10 | 10% |
Agricultural and Biological Sciences | 8 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 8% |
Other | 10 | 10% |
Unknown | 31 | 32% |